Lehman David Aaron (CIK 1354228) reported 28 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-06-03). Recent activity: Sell LUNG (3,876 shares), Sell LUNG (2,264 shares), Sell LUNG (3,539 shares), Sell LUNG (4,915 shares), Sell LUNG (1,163 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-03 | Pulmonx Corp (LUNG) | GENERAL COUNSEL | Sell | 3,876 | $5,969 |
| 2026-06-03 | Pulmonx Corp (LUNG) | GENERAL COUNSEL | Sell | 2,264 | $3,487 |
| 2026-06-03 | Pulmonx Corp (LUNG) | GENERAL COUNSEL | Sell | 3,539 | $5,450 |
| 2026-06-03 | Pulmonx Corp (LUNG) | GENERAL COUNSEL | Sell | 4,915 | $7,569 |
| 2026-03-04 | Pulmonx Corp (LUNG) | GENERAL COUNSEL | Sell | 1,163 | $1,663 |
| 2026-03-04 | Pulmonx Corp (LUNG) | GENERAL COUNSEL | Sell | 4,433 | $6,339 |
| 2026-03-04 | Pulmonx Corp (LUNG) | GENERAL COUNSEL | Sell | 2,590 | $3,704 |
| 2026-03-04 | Pulmonx Corp (LUNG) | GENERAL COUNSEL | Sell | 4,051 | $5,793 |
| 2026-03-04 | Pulmonx Corp (LUNG) | GENERAL COUNSEL | Buy | 150,000 | $0 |
| 2025-12-03 | Pulmonx Corp (LUNG) | GENERAL COUNSEL | Sell | 3,401 | $5,340 |
| 2025-12-03 | Pulmonx Corp (LUNG) | GENERAL COUNSEL | Sell | 3,725 | $5,848 |
| 2025-12-03 | Pulmonx Corp (LUNG) | GENERAL COUNSEL | Sell | 2,176 | $3,416 |
| 2025-12-03 | Pulmonx Corp (LUNG) | GENERAL COUNSEL | Sell | 976 | $1,532 |
| 2025-09-03 | Pulmonx Corp (LUNG) | GENERAL COUNSEL | Sell | 929 | $1,486 |
| 2025-09-03 | Pulmonx Corp (LUNG) | GENERAL COUNSEL | Sell | 3,541 | $5,666 |
| 2025-09-03 | Pulmonx Corp (LUNG) | GENERAL COUNSEL | Sell | 2,068 | $3,309 |
| 2025-09-03 | Pulmonx Corp (LUNG) | GENERAL COUNSEL | Sell | 3,231 | $5,170 |
| 2025-06-04 | Pulmonx Corp (LUNG) | GENERAL COUNSEL | Sell | 535 | $1,680 |
| 2025-06-04 | Pulmonx Corp (LUNG) | GENERAL COUNSEL | Sell | 943 | $2,952 |
| 2025-06-04 | Pulmonx Corp (LUNG) | GENERAL COUNSEL | Sell | 3,597 | $11,259 |
| 2025-06-04 | Pulmonx Corp (LUNG) | GENERAL COUNSEL | Sell | 2,099 | $6,570 |
| 2025-06-04 | Pulmonx Corp (LUNG) | GENERAL COUNSEL | Sell | 3,283 | $10,276 |
| 2025-03-05 | Pulmonx Corp (LUNG) | GENERAL COUNSEL | Sell | 669 | $4,777 |
| 2025-03-05 | Pulmonx Corp (LUNG) | GENERAL COUNSEL | Sell | 1,177 | $8,404 |
| 2025-03-05 | Pulmonx Corp (LUNG) | GENERAL COUNSEL | Sell | 4,490 | $32,059 |
Source: SEC Form 4 filings · as of 2026-06-03